<- Go Home

Eon Labs, Inc.

Eon Labs, Inc., a generic pharmaceutical company, develops, manufactures, and distributes prescription pharmaceutical products in the United States. The company focuses on drugs in various solid oral dosage forms, utilizing both immediate and sustained release delivery, in tablet, multiple layer tablet, film-coated tablet, and capsule forms. It sells its products primarily to drug wholesalers, national drug chains, and mail order accounts, as well as Health Maintenance Organizations (HMOs). The company has a strategic relationship with Hexal Pharmaceuticals, Inc. to develop generic transdermal patch products that utilize transdermal patch delivery technology. Eon Labs, Inc. was formerly known as Eon Labs Manufacturing, Inc. The company was incorporated in 1992 and is based in Lake Success, New York. As of January 28, 2021, Eon Labs, Inc. operates as a subsidiary of Sandoz International GmbH.

Market Cap

$2.8B

Volume

899.4K

Cash and Equivalents

$63.3M

EBITDA

$195.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$238.4M

Profit Margin

55.74%

52 Week High

$31.15

52 Week Low

$21.05

Dividend

N/A

Price / Book Value

5.85

Price / Earnings

24.79

Price / Tangible Book Value

6.78

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$184.2M

Return on Equity

27.25%

Return on Assets

22.13

Cash and Short Term Investments

$229.0M

Debt

N/A

Equity

$470.5M

Revenue

$427.8M

Unlevered FCF

$51.0M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches